Resources

We took a snapshot of the 8 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from failing to monitor the water purification system to personnel not wearing appropriate clothing to prevent contamination. From pharmaceuticals in California, Singapore, and more, here they are: Badrivishal Chemicals & Pharmaceuticals, Maharashtra, India – 4 […]

We took a snapshot of the 7 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from failing to maintain complete data (again) to failing to produce suitable water. From pharmaceuticals in Japan, Illinois, and more, here they are (starting with the most recent): Megafine Pharma, Mumbai, India – 4 violations:Failure […]

What is the Future of Outsourcing Facilities? PART II Policies, Enforcement, and Predictions Policies:In this section, we will address policies and guidance that the FDA has published since the end of 2013, look at enforcement activities in this area, and make some predictions for the future of this market segment. According to the FDA website,FDA […]

The Real Story Behind Outsourcing Facilities: Are They Still Worth It and Were They Ever? PART I History and Background: The New England Compounding Center (NECC) preparation and shipment of contaminated injectable products across state lines in 2012 created a firestorm of publicity and enforcement actions. More than 750 patients in twenty states developed a fungal […]

We took a snapshot of the 10 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from products not meeting “the definition and standard for chocolate” to sites “refusing to permit the FDA inspection” altogether. From pharmaceuticals in Italy, Pennsylvania, and more, here they are (starting with the most recent): Berkeley […]

How to Prepare for a GMP Inspection for Small and Virtual Companies Preparing for GMP inspections, particularly pre-approval inspections, can be a challenge when resources are limited and staff may have little expertise in these important activities. This becomes especially complex for start-up companies that are virtual, or essentially virtual, and rely on contract manufacturers […]

We took a snapshot of the 5 warning letters the FDA sent to pharmaceutical companies last month. Drug manufacturing violations ranged from failing to put expiration dates on containers to failing to put soap in the bathrooms. From pharmaceuticals in Canada, Spain, and more, here they are (starting with the most recent): Horizon Pharmaceuticals, Inc., […]

FSMA is Here. How Do You Manage 1,000 Food Suppliers? The advent of the FSMA in the US means that everyone in your supplier network can expect an inspector to knock at some point, underlining the imperative for supplier accountability to compliance teams. Brand revenue and reputation ride on the outcome. This means effectively keeping […]

  Changes in Regulatory and GMP Intelligence Surveillance, analysis and communication of regulatory and GMP intelligence has evolved over the past decade. The individual(s) tasked with this activity within pharma companies require broad experience in regulatory affairs and GMP compliance. The individual(s) must have sufficient historical perspective to compare and contrast new requirements with those they […]

An Alternative to GMP Quality System Auditing in the Pharma Industry Executive Summary: Historically, a quality systems approach to GMP auditing has become common practice. However, this systems approach does not routinely address the essential input into the system – the data.Data integrity issues have drastically increased in the last year – and not just […]